Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Gudi, Viktoria ^a,b   Škuljec, Jelena ^a,b   Yildiz, Özlem ^a   Frichert, Konstantin ^a   Skripuletz, Thomas ^a   Moharregh Khiabani, Darius ^a   Voß, Elke ^a   Wissel, Kirsten ^a   Wolter, Sabine ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CILIARY NEUROTROPHIC FACTOR; CUPRIZONE; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; HEPATIC GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; NESTIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL ISOLATION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; GENE EXPRESSION REGULATION; GRAY MATTER; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMYELINIZATION; TISSUE DIFFERENTIATION; UPREGULATION; WHITE MATTER; ANIMAL; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; TIME; WOUND HEALING;

MURINAE;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERMEDIATE FILAMENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; RNA, MESSENGER; TIME FACTORS; WOUND HEALING;

EID: 79960770974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022623     Document Type: Article

References (55)

1. Mirowska-Guzel D, (2009) The role of neurotrophic factors in the pathology and treatment of multiple sclerosis. Immunopharmacol Immunotoxicol 31: 32-38.
2. Frota ER, Rodrigues DH, Donadi EA, Brum DG, Maciel DR, et al. (2009) Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. Neurosci Lett 460: 130-132.
3. Althaus HH, Kloppner S, Klopfleisch S, Schmitz M, (2008) Oligodendroglial cells and neurotrophins: a polyphonic cantata in major and minor. J Mol Neurosci 35: 65-79.
4. Rosenberg SS, Ng BK, Chan JR, (2006) The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol 16: 288-294.
5. Butt AM, Berry M, (2000) Oligodendrocytes and the control of myelination in vivo: new insights from the rat anterior medullary velum. J Neurosci Res 59: 477-488.
6. Franklin RJ, Hinks GL, (1999) Understanding CNS remyelination: clues from developmental and regeneration biology. J Neurosci Res 58: 207-213.
7. Miller RH, Mi S, (2007) Dissecting demyelination. Nat Neurosci 10: 1351-1354.
8. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA, (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5: 603-614.
9. Wolswijk G, Noble M, (1992) Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol 118: 889-900.
10. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC, (2002) Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22: 8574-8585.
11. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ, (2004) Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25: 252-262.
12. Mozell RL, McMorris FA, (1991) Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J Neurosci Res 30: 382-390.
13. Ye P, Carson J, D'Ercole AJ, (1995) In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15: 7344-7356.
14. McKinnon RD, Piras G, Ida JA Jr, Dubois-Dalcq M, (1993) A role for TGF-beta in oligodendrocyte differentiation. J Cell Biol 121: 1397-1407.
15. Diemel LT, Jackson SJ, Cuzner ML, (2003) Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages. J Neurosci Res 74: 858-867.
16. Stankoff B, Aigrot MS, Noel F, Wattilliaux A, Zalc B, et al. (2002) Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci 22: 9221-9227.
17. Barres BA, Burne JF, Holtmann B, Thoenen H, Sendtner M, et al. (1996) Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci 8: 146-156.
18. Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ, (2002) Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 22: 6041-6051.
19. Mayer M, Bhakoo K, Noble M, (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120: 143-153.
20. van Horssen J, Brink BP, de Vries HE, van d V, Bo L, (2007) The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66: 321-328.
21. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ, (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9: 323-331.
22. Albert M, Antel J, Bruck W, Stadelmann C, (2007) Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 17: 129-138.
23. Matsushima GK, Morell P, (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11: 107-116.
24. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, et al. (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172: 1053-1061.
25. Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, et al. (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283: 127-138.
26. Rehbinder C, Baneux P, Forbes D, van Herck H, Nicklas W, et al. (1996) FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management, November 1995. Lab Anim 30: 193-208.
27. Paxinos G, Franklin KBJ, (2001) The Mouse Brain in Stereotaxic Coordinates New York Academic Press.
28. Havenith CE, Askew D, Walker WS, (1998) Mouse resident microglia: isolation and characterization of immunoregulatory properties with naive CD4+ and CD8+ T-cells. Glia 22: 348-359.
29. Cardona AE, Huang D, Sasse ME, Ransohoff RM, (2006) Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Protoc 1: 1947-1951.
30. de Haas AH, Boddeke HW, Brouwer N, Biber K, (2007) Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions. Glia 55: 1374-1384.
31. Lindner M, Heine S, Haastert K, Garde N, Fokuhl J, et al. (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 34: 105-114.
32. Hesse A, Wagner M, Held J, Bruck W, Salinas-Riester G, et al. (2009) In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis.
33. Kahn MA, Huang CJ, Caruso A, Barresi V, Nazarian R, et al. (1997) Ciliary neurotrophic factor activates JAK/Stat signal transduction cascade and induces transcriptional expression of glial fibrillary acidic protein in glial cells. J Neurochem 68: 1413-1423.
34. Ikeda T, Koo H, Xia YX, Ikenoue T, Choi BH, (2002) Bimodal upregulation of glial cell line-derived neurotrophic factor (GDNF) in the neonatal rat brain following ischemic/hypoxic injury. Int J Dev Neurosci 20: 555-562.
35. Lee YJ, Jin JK, Jeong BH, Carp RI, Kim YS, (2006) Increased expression of glial cell line-derived neurotrophic factor (GDNF) in the brains of scrapie-infected mice. Neurosci Lett 410: 178-182.
36. Miyazaki H, Nagashima K, Okuma Y, Nomura Y, (2001) Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res 922: 165-172.
37. Suter-Crazzolara C, Unsicker K, (1996) GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells. Brain Res Mol Brain Res 41: 175-182.
38. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, et al. (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19: 1708-1716.
39. Hashimoto M, Nitta A, Fukumitsu H, Nomoto H, Shen L, et al. (2005) Involvement of glial cell line-derived neurotrophic factor in activation processes of rodent macrophages. J Neurosci Res 79: 476-487.
40. Satake K, Matsuyama Y, Kamiya M, Kawakami H, Iwata H, et al. (2000) Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury. Neuroreport 11: 3877-3881.
41. Hendriks JJ, Slaets H, Carmans S, de Vries HE, Dijkstra CD, et al. (2008) Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 204: 52-57.
42. Kerr BJ, Patterson PH, (2004) Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 188: 391-407.
43. Sugiura S, Lahav R, Han J, Kou SY, Banner LR, et al. (2000) Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci 12: 457-466.
44. Hinks GL, Franklin RJ, (1999) Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14: 153-168.
45. Fushimi S, Shirabe T, (2004) Expression of insulin-like growth factors in remyelination following ethidium bromide-induced demyelination in the mouse spinal cord. Neuropathology 24: 208-218.
46. Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, et al. (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61: 251-262.
47. Bansal R, Pfeiffer SE, (1997) Regulation of oligodendrocyte differentiation by fibroblast growth factors. Adv Exp Med Biol 429: 69-77.
48. Goddard DR, Berry M, Kirvell SL, Butt AM, (2001) Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol Cell Neurosci 18: 557-569.
49. Copelman CA, Cuzner ML, Groome N, Diemel LT, (2000) Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody-mediated demyelination. Glia 30: 342-351.
50. Yan H, Rivkees SA, (2002) Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 69: 597-606.
51. Lalive PH, Paglinawan R, Biollaz G, Kappos EA, Leone DP, et al. (2005) TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur J Immunol 35: 727-737.
52. Albrecht PJ, Murtie JC, Ness JK, Redwine JM, Enterline JR, et al. (2003) Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol Dis 13: 89-101.
53. Power J, Mayer-Proschel M, Smith J, Noble M, (2002) Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. Dev Biol 245: 362-375.
54. Dallner C, Woods AG, Deller T, Kirsch M, Hofmann HD, (2002) CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain. Glia 37: 374-378.
55. Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF, (2003) Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25: 116-126.